Canada Markets closed

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
67.74+2.14 (+3.26%)
At close: 04:00PM EDT
68.20 +0.46 (+0.68%)
After hours: 06:17PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.97
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3180.59
52 Week Low 337.08
50-Day Moving Average 357.20
200-Day Moving Average 380.02

Share Statistics

Avg Vol (3 month) 31.3M
Avg Vol (10 day) 31.48M
Shares Outstanding 574.42M
Implied Shares Outstanding 6N/A
Float 868.69M
% Held by Insiders 19.75%
% Held by Institutions 186.25%
Shares Short (Jul 14, 2022) 47.22M
Short Ratio (Jul 14, 2022) 44.48
Short % of Float (Jul 14, 2022) 410.93%
Short % of Shares Outstanding (Jul 14, 2022) 49.51%
Shares Short (prior month Jun 14, 2022) 46.99M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-939.44%

Management Effectiveness

Return on Assets (ttm)-23.16%
Return on Equity (ttm)-49.15%

Income Statement

Revenue (ttm)37.86M
Revenue Per Share (ttm)0.52
Quarterly Revenue Growth (yoy)74.60%
Gross Profit (ttm)-186.75M
EBITDA -348.62M
Net Income Avi to Common (ttm)-368.56M
Diluted EPS (ttm)-3.38
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)855.25M
Total Cash Per Share (mrq)11.27
Total Debt (mrq)71.82M
Total Debt/Equity (mrq)7.53
Current Ratio (mrq)6.94
Book Value Per Share (mrq)14.89

Cash Flow Statement

Operating Cash Flow (ttm)-252.46M
Levered Free Cash Flow (ttm)-151.54M